Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy

With the success of immune checkpoint inhibitors (ICIs), significant progress has been made in the field of cancer immunotherapy. Despite the long-lasting outcomes in responders, the majority of patients with cancer still do not benefit from this revolutionary therapy. Increasing evidence suggests t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Zhao, Qin, Zhang, Yuyu, Liu, Zijing, Zheng, Zhuangzhuang, Liu, Shiyu, Meng, Lingbin, Xin, Ying, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796640/
https://www.ncbi.nlm.nih.gov/pubmed/33422072
http://dx.doi.org/10.1186/s13046-020-01820-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796640/
https://www.ncbi.nlm.nih.gov/pubmed/33422072
http://dx.doi.org/10.1186/s13046-020-01820-7

Ejemplares similares